Frequency of CD8+T lymphocyte expression in HCV induced Hepatocellular carcinoma

Efficacy of Using Neutrophil to Lymphocyte Ratio and Interleukin 6 as Outcome Predictors of Interventional Treatment of Hepatocellular Carcioma

Evaluation of CD4+CD25+ regulatory T cells in patients with hepatocellular carcinoma and liver cirrhosis

Assessment of CD4+CD25+ Regulatory T Lymphocytes Cells in Chronic Hepatitis C, Chronic Hepatitis C– Associated Cirrhosis and Hepatocellular Carcinoma Patients

Characterization and Outcomes of Hepatocellular Carcinoma in Chronic HCV or HBV Monoinfection

Role of CD8 Cytotoxic T Lymphocytes in Hepatocellular Carcinoma: An Immunohistochemical Study

High expression of the checkpoint molecule PD-1 on conventional CD4+ and regulatory T cells in the peripheral blood of Hepatocellular carcinoma patients

Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ?

Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents

Impact of Direct-Acting Antivirals on Recurrence of Hepatocellular Carcinoma after Curative Treatment.